Capital Fund Management (CFM)’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-8,300
Closed -$1.47M 1742
2020
Q1
$1.47M Sell
8,300
-136,200
-94% -$25.6M 0.02% 625
2019
Q4
$27.6M Sell
144,500
-26,800
-16% -$4.83M 0.22% 109
2019
Q3
$28.8M Sell
171,300
-151,900
-47% -$24.7M 0.26% 97
2019
Q2
$54.1M Buy
323,200
+8,500
+3% +$1.18M 0.49% 21
2019
Q1
$46.1M Sell
314,700
-59,600
-16% -$8.64M 0.41% 36
2018
Q4
$50M Sell
374,300
-124,200
-25% -$20.4M 0.44% 33
2018
Q3
$95M Buy
498,500
+8,100
+2% +$1.49M 0.52% 19
2018
Q2
$81.8M Sell
490,400
-198,100
-29% -$31.8M 0.43% 26
2018
Q1
$116M Sell
688,500
-88,900
-11% -$14.9M 0.7% 2
2017
Q4
$127M Buy
777,400
+576,700
+287% +$103M 0.7% 12
2017
Q3
$41.1M Buy
200,700
+149,800
+294% +$34.8M 0.3% 91
2017
Q2
$12.4M Sell
50,900
-92,500
-65% -$21.7M 0.1% 260
2017
Q1
$34.3M Sell
143,400
-83,600
-37% -$19.5M 0.29% 94
2016
Q4
$47.7M Buy
227,000
+218,900
+2,702% +$45.3M 0.41% 47
2016
Q3
$1.87M Buy
8,100
+4,400
+119% +$1.08M 0.02% 782
2016
Q2
$855K Buy
+3,700
New +$853K 0.01% 1003
2016
Q1
Sell
-2,800
Closed -$875K 1984
2015
Q4
$875K Sell
2,800
-3,400
-55% -$1.01M 0.01% 918
2015
Q3
$1.69M Buy
+6,200
New +$1.9M 0.02% 667
2015
Q1
Sell
-6,800
Closed -$1.75M 1847
2014
Q4
$1.75M Sell
6,800
-20,400
-75% -$5.1M 0.02% 720
2014
Q3
$6.56M Sell
27,200
-22,800
-46% -$5.1M 0.07% 341
2014
Q2
$11.2M Buy
50,000
+26,900
+116% +$5.57M 0.12% 209
2014
Q1
$4.75M Sell
23,100
-1,700
-7% -$337K 0.06% 386
2013
Q4
$4.17M Buy
24,800
+10,200
+70% +$1.59M 0.05% 442
2013
Q3
$2.1M Sell
14,600
-12,600
-46% -$1.68M 0.03% 622
2013
Q2
$3.43M Buy
+27,200
New +$3.08M 0.05% 460

Other funds holding AGN

Capital Fund Management (CFM)'s AGN Position: Q2 2020 in Review

Capital Fund Management (CFM) sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 21,914 shares — an estimated $3.88M sold.

Capital Fund Management (CFM) first reported a position in AGN in Q3 2014 and held it in 11 quarters. The position peaked at $61.3M in Q4 2017. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Capital Fund Management (CFM) reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Capital Fund Management (CFM) sold 21,914 Allergan plc shares in Q2 2020, an estimated $3.88M.
  • Capital Fund Management (CFM) first reported a position in Allergan plc in Q3 2014 and held it in 11 quarters.
  • Capital Fund Management (CFM)'s Allergan plc position peaked at $61.3M in Q4 2017.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Capital Fund Management (CFM)'s 13F filing for Q2 2020, filed 13 Aug 2020.